Zoekresultaten - 1 result

Regulatory issues regarding manufacture and control of vaccine adjuvants. The EU situation.

EMA guideline EMEA / CHMP / QWP /39695½006 (Guideline on excipients in the dossier for marketing authorization of a medicinal product), adjuvants, being no active substance, are categorised as ...

QR code

QR code for this page URL